Cargando…
An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotrypsin-like...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611036/ https://www.ncbi.nlm.nih.gov/pubmed/34815498 http://dx.doi.org/10.1038/s41598-021-02266-3 |
_version_ | 1784603221410447360 |
---|---|
author | Liao, Qi Chen, Ziyu Tao, Yanlin Zhang, Beibei Wu, Xiaojun Yang, Li Wang, Qingzhong Wang, Zhengtao |
author_facet | Liao, Qi Chen, Ziyu Tao, Yanlin Zhang, Beibei Wu, Xiaojun Yang, Li Wang, Qingzhong Wang, Zhengtao |
author_sort | Liao, Qi |
collection | PubMed |
description | The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotrypsin-like protease (3CLpro) in SARS-CoV-2 serve as a promising anti-virus target due to its essential role in the regulation of virus reproduction. Here, we report an improved integrated approach to identify effective 3CLpro inhibitors from effective Chinese herbal formulas. With this approach, we identified the 5 natural products (NPs) including narcissoside, kaempferol-3-O-gentiobioside, rutin, vicenin-2 and isoschaftoside as potential anti-SARS-CoV-2 candidates. Subsequent molecular dynamics simulation additionally revealed that these molecules can be tightly bound to 3CLpro and confirmed effectiveness against COVID-19. Moreover, kaempferol-3-o-gentiobioside, vicenin-2 and isoschaftoside were first reported to have SARS-CoV-2 3CLpro inhibitory activity. In summary, this optimized integrated strategy for drug screening can be utilized in the discovery of antiviral drugs to achieve rapid acquisition of drugs with specific effects on antiviral targets. |
format | Online Article Text |
id | pubmed-8611036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86110362021-11-26 An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro Liao, Qi Chen, Ziyu Tao, Yanlin Zhang, Beibei Wu, Xiaojun Yang, Li Wang, Qingzhong Wang, Zhengtao Sci Rep Article The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotrypsin-like protease (3CLpro) in SARS-CoV-2 serve as a promising anti-virus target due to its essential role in the regulation of virus reproduction. Here, we report an improved integrated approach to identify effective 3CLpro inhibitors from effective Chinese herbal formulas. With this approach, we identified the 5 natural products (NPs) including narcissoside, kaempferol-3-O-gentiobioside, rutin, vicenin-2 and isoschaftoside as potential anti-SARS-CoV-2 candidates. Subsequent molecular dynamics simulation additionally revealed that these molecules can be tightly bound to 3CLpro and confirmed effectiveness against COVID-19. Moreover, kaempferol-3-o-gentiobioside, vicenin-2 and isoschaftoside were first reported to have SARS-CoV-2 3CLpro inhibitory activity. In summary, this optimized integrated strategy for drug screening can be utilized in the discovery of antiviral drugs to achieve rapid acquisition of drugs with specific effects on antiviral targets. Nature Publishing Group UK 2021-11-23 /pmc/articles/PMC8611036/ /pubmed/34815498 http://dx.doi.org/10.1038/s41598-021-02266-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Liao, Qi Chen, Ziyu Tao, Yanlin Zhang, Beibei Wu, Xiaojun Yang, Li Wang, Qingzhong Wang, Zhengtao An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title | An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title_full | An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title_fullStr | An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title_full_unstemmed | An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title_short | An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro |
title_sort | integrated method for optimized identification of effective natural inhibitors against sars-cov-2 3clpro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611036/ https://www.ncbi.nlm.nih.gov/pubmed/34815498 http://dx.doi.org/10.1038/s41598-021-02266-3 |
work_keys_str_mv | AT liaoqi anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT chenziyu anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT taoyanlin anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT zhangbeibei anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wuxiaojun anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT yangli anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wangqingzhong anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wangzhengtao anintegratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT liaoqi integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT chenziyu integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT taoyanlin integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT zhangbeibei integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wuxiaojun integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT yangli integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wangqingzhong integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro AT wangzhengtao integratedmethodforoptimizedidentificationofeffectivenaturalinhibitorsagainstsarscov23clpro |